Other
Acute Mountain Sickness
0
Pipeline Programs↗
1
Active Trials↗
3
Companies Involved↗
Acute Mountain Sickness is an early-stage landscape with 0 programs across 3 companies. The most active players are Otsuka, Eli Lilly, Tasly Pharmaceuticals, Inc..
Intelligence
Pipeline Metrics
Competitive Density
Pipeline Velocity
Mech. Concentration
Completion Rate
Attrition Rate
Competition
Competitive Landscape
Bubble size = clinical trials
Approved
Phase 3
Phase 2
Phase 1
Preclinical
Key Players
Top Companies Companies ranked by the number of pipeline programs they run for this disease.
Pipeline
Programs by Phase
No pipeline programs currently tracked for this disease.
Analysis
Trial Status
12
clinical trials
Completed10 · 83%
Unknown status1 · 8%
Not yet recruiting1 · 8%
Clinical Trials
Trial Activity
12 trials
Can Rhodiola Crenulata Intake Improve Oxygen Saturation and Decrease the Incidence of Acute Mountain Sickness
Completed·—·Phase 2·NCT01536288·125 enrolled
Inhaled Budesonide and Acute Mountain Sickness
Completed·—·Phase 1·NCT02811016·51 enrolled
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)